Bliss GVS Pharma Limited (BOM:506197)
India · Delayed Price · Currency is INR 396.35
+15.25 (4.00%)
At close: May 27, 2026
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 41.93 billion as of May 27, 2026. Its market cap has increased by 257.52% in one year.
Market Cap
41.93B
Enterprise Value
40.81B
Revenue
8.68B
Ranking
n/a
PE Ratio
38.89
Stock Price
396.35
Market Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 41.93B, an increase of 417,028.07%. That is a compound annual growth rate of 40.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 41.93B | 142.42% |
| Dec 31, 2025 | 17.30B | -0.33% |
| Dec 31, 2024 | 17.35B | 33.41% |
| Dec 29, 2023 | 13.01B | 72.15% |
| Dec 30, 2022 | 7.56B | -29.58% |
| Dec 31, 2021 | 10.73B | -48.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Procter & Gamble Health | 103.70B |
| CORONA Remedies | 102.46B |
| Sanofi India | 73.64B |
| FDC Limited | 65.73B |
| Novartis India | 34.92B |
| Gufic Biosciences | 31.89B |
| Hikal | 27.18B |
| Unichem Laboratories | 24.89B |